Skip to main content
. 2025 Mar 28;13:85. doi: 10.1186/s40168-025-02087-w

Table 2.

Demographic, genotype distribution and treatment outcome of halitosis patients in the prospective study (n = 60)

Characteristics Genotypes
Non-AVI/AVI
(n = 40)
AVI/AVI
(n = 20)
P value
Demographic Age, mean ± SD, y 33.83 ± 6.64 35.90 ± 7.01 0.2757 a
Male sex, n (%) 16 (40.0%) 9 (45.0%) 0.7111 b
PPD (mm) Baseline 2.41 ± 0.47 2.57 ± 0.74 0.3076 a
1-month 1.84 ± 0.38 2.01 ± 0.50 0.2349 a
3-month 1.88 ± 0.39 1.87 ± 0.46 0.9360a
6-month 2.00 ± 0.52 2.09 ± 0.46 0.5520 a
Treatment outcome Improved 27 2 0.0009 b
Persistent 13 18

aunpaired student’s t test

bContinuity corrected chi-square test